Loading
Cervical Cancer and HPV Research / Head and Neck Cancer Studies / Photodynamic Therapy Research Studies · Journal article
Frontiers in Oncology · August 7, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review that synthesizes mechanisms of action and existing clinical evidence for photodynamic therapy (PDT) as a minimally invasive alternative to excisional procedures for high-grade cervical intraepithelial neoplasia. The source presents conceptual and mechanistic arguments supported by references to prior clinical data showing reduction of viral load and high regression rates, but does not report new trial results, meta-analyses, or quantified outcomes from a systematic literature review.
Journal article. Younger women with cervical intraepithelial neoplasia grade 2 (CIN2) or high-grade squamous intraepithelial lesions (HSIL), hrHPV-infected.
5-ALA-PDT selectively targets dysplastic cells while preserving cervical anatomical and functional integrity PDT counteracts hrHPV inhibition of autophagy, facilitating viral clearance and restoring immune responses Clinical data support reduction of viral load and high regression rates of HSIL with PDT
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The review positions PDT as a potentially tissue-sparing alternative to loop electrosurgical excision (LEEP) and conization for young women, emphasizing preservation of cervical integrity and obstetric outcomes. However, clinicians should recognize this is a mechanistic and conceptual summary rather than evidence from a definitive trial.
This is a narrative review synthesizing mechanistic concepts and existing clinical data without presenting new primary evidence, new trial results, or a systematic analysis of the literature.
The review positions PDT as a potentially tissue-sparing alternative to loop electrosurgical excision (LEEP) and conization for young women, emphasizing preservation of cervical integrity and obstetric outcomes. However, clinicians should recognize this is a mechanistic and conceptual summary rather than evidence from a definitive trial.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Cervical cancer, driven by persistent infection with high-risk human papillomavirus (hrHPV), remains a major global health burden. While conventional excisional procedures such as loop electrosurgical excision (LEEP) and conization are effective in treating high-grade squamous intraepithelial lesions (HSIL), which include cervical intraepithelial neoplasia grades 2 and 3 (CIN2 and CIN3, respectively), they are associated with significant risks to cervical integrity and adverse obstetric outcomes. Photodynamic therapy (PDT), particularly using the protoporphyrin IX precursors 5-aminolevulinic acid (5-ALA) and its derivatives, hexyl aminolevulinate (HAL), and methyl aminolevulinate (MAL), has emerged as an alternative and minimally invasive strategy to treat younger women with CIN2. Here, we delineate the cellular and molecular mechanisms that underlie PDT’s efficacy in the treatment of cervical lesions. We emphasize the ability of 5-ALA-PDT to selectively target dysplastic cells while preserving the anatomical and functional integrity of the cervix. Central to this therapeutic effect is the modulation of cell death pathways. Specifically, we discuss how PDT counteracts the inhibitory effects of hrHPV on autophagy, thereby facilitating viral clearance and restoring homeostatic immune responses. Furthermore, we delineate the multifaceted cell death modalities orchestrated by 5-ALA-PDT, underscoring their pivotal role in the targeted eradication of hrHPV-transformed cervical cells. Clinical data supporting the reduction of viral load and high regression rates of HSIL are summarized, alongside a critical evaluation of current treatment protocols. Finally, we propose that the future of cervical PDT lies in precision oncology. This highlights the need to focus on the identification of resistance biomarkers and the development of therapeutic strategies that exploit the synergistic combination of PDT with molecular modulators to optimize clinical outcomes and prevent recurrence.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.